MedPath

HS-10380

Generic Name
HS-10380

Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia

Phase 1
Not yet recruiting
Conditions
Schizophrenia
Interventions
Drug: Placebo
First Posted Date
2023-07-28
Last Posted Date
2023-07-28
Lead Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Target Recruit Count
112
Registration Number
NCT05964790

A Study of HS-10380 in Chinese Participants

Phase 1
Recruiting
Conditions
Schizophrenia
Interventions
Drug: Placebo
First Posted Date
2022-07-29
Last Posted Date
2023-03-09
Lead Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Target Recruit Count
76
Registration Number
NCT05480592
Locations
🇨🇳

Shanghai Mental Health Center, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath